Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stools and diarrhoea are among the more disruptive side effects people notice on Wegovy, particularly in the first weeks of treatment or after a dose increase. The good news is that this is well-documented and, for most people, manageable. Understanding why it happens helps you make sensible decisions about food, hydration and timing — and knowing when loose stools cross a line into something that needs medical attention is equally important. Wegovy (semaglutide) is a prescription-only medicine that a GPhC-registered prescriber assesses you for individually; any persistent or severe bowel changes should be discussed with your clinical team rather than managed alone. This page covers the practical steps most people find helpful, when to seek help, and what to watch for alongside diarrhoea.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows the rate at which food moves through the stomach and upper gut. That slower gastric emptying, which is central to how Wegovy helps with weight management, also changes the rhythm of the digestive system further down. For some people the result is constipation; for others, particularly in the early weeks, it is looser stools or outright diarrhoea. The broader pattern of Wegovy-related diarrhoea is consistent across the clinical trials and the real-world experience that has followed: it tends to peak around dose-increase points and gradually settles as the body adjusts.
The NHS semaglutide patient information page lists diarrhoea as a common side effect, meaning it affects more than one in ten people. It is not a sign that treatment is failing or that the medicine is harming you, but it does deserve attention, both practically and medically. Knowing the mechanism helps you accept that managing it is mostly about timing and food choices, not stopping treatment altogether.
The decision most people face is not whether to tolerate diarrhoea but how to reduce it without abandoning treatment that may be working well for them. Several straightforward adjustments tend to help, and our prescribers discuss all of them during consultations.
Eat smaller portions, more slowly, and keep meals lower in fat for now. Fatty foods are one of the most reliable triggers for loose stools on GLP-1 treatment, they slow gastric emptying further and can overwhelm an already-sensitive gut. The same applies to very spicy meals and large quantities of raw fibre early in treatment. Bland, cooked foods (rice, plain bread, boiled vegetables) are easier to tolerate while symptoms are present. Some people find that eating earlier in the evening, so the gut has more time to settle overnight, makes mornings considerably easier, useful if you have to be out of the house for the school run by eight.
Staying hydrated is not optional. Each episode of diarrhoea loses fluid and electrolytes; replacing both steadily through the day reduces the risk of dehydration-related fatigue and protects kidney function. Plain water, diluted fruit juice and oral rehydration sachets from a pharmacy all work. For guidance on avoiding diarrhoea on Wegovy before it starts, dietary timing tends to matter more than people expect.
Over-the-counter loperamide (the active ingredient in most anti-diarrhoea tablets) is widely used for short-term management, and if you want to understand how to stop diarrhoea on semaglutide more broadly, there are several practical steps worth knowing before reaching for medication. It is generally compatible with semaglutide, but check with your prescriber or a pharmacist before using it regularly, particularly if you also take other medicines.
Most cases resolve within a few days as the gut adjusts to the current dose. The picture that warrants prompt contact with a healthcare professional is different: diarrhoea that continues for more than two or three days without any let-up, signs of dehydration (dizziness, very dark urine, dry mouth, inability to keep fluids down), or diarrhoea accompanied by severe abdominal pain.
Severe, persistent stomach pain (especially pain that radiates towards the back) should not be dismissed as ordinary GI side effects. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines. Pancreatitis can present alongside gut symptoms and requires urgent medical assessment, not watchful waiting. Details of what to look for are covered in the guidance on severe diarrhoea on Wegovy.
If you experience a suspected side effect, including anything unexpected or severe, you can report it directly through the MHRA Yellow Card scheme. Reports from patients are taken seriously and contribute to ongoing safety monitoring of medicines like Wegovy.
If diarrhoea is persistent enough to affect your day-to-day life or your ability to stay hydrated, that is worth raising at your next clinical review rather than pushing through. Prescribers may consider slowing the dose-escalation schedule, staying at the current dose for an extra month, or reviewing whether any other medicines or foods are making symptoms worse. It is rarely a reason to stop treatment entirely. The fuller picture of Wegovy side effects across the gastrointestinal system is worth understanding, because the same management principles often apply across symptoms.
At nume, a real clinician (not an automated screening tool) reads your consultation answers, and that review continues at every repeat. Side-effect concerns raised through our aftercare team reach a prescriber the same day, seven days a week. If you are considering Wegovy and want to discuss your individual risk profile honestly before starting, starting a free consultation is where that conversation begins. You can also read more about how Wegovy works and what a typical treatment course looks like. The clinical team profile at our prescribers page sets out who is reviewing your case.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.